Topical Application of AS101 for the Treatment of Psoriasis
Status:
Withdrawn
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
This protocol relates to a phase II randomized double blind, placebo controlled study of the
AS101 topical application for the treatment of mild to moderate Psoriasis.